Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Nausea, Nervousness, Oligomenorrhoea
Clinical narrative: Emesis; Loose stools; Extended menstrual cycle; Nausea; Dizziness; Very nervous; Itching at the injection site; Redness at the injection site; This is a spontaneous report received from a contactable reporter (nurse). The reporter is the patient.  A 32-year-old female patient (unknown if pregnant) received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), administered in left arm, administration date 18Nov2021 at 20:00 (Batch/Lot number: unknown) at the age of 32 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Asthma"; "Allergic rhinitis"; "Fruit allergy", notes: Known allergies: Kiwi, olives; "Food allergy", notes: Known allergies: Coconut and "Penicillin allergy", notes: Known Allergies: Penicillin. Concomitant medications included: ZYRTEC; ALBUTEROL and MELATONIN.  The following information was reported: NAUSEA (non-serious) with onset 18Nov2021 at 20:15, outcome "recovered with sequelae" (an unknown date in Nov2021), described as "Nausea"; DIZZINESS (non-serious) with onset 18Nov2021 at 20:15, outcome "recovered with sequelae" (an unknown date in Nov2021), described as "Dizziness"; VOMITING (non-serious) with onset 19Nov2021 at 08:00, outcome "recovered with sequelae" (an unknown date in Nov2021), described as "Emesis"; DIARRHOEA (non-serious) with onset 19Nov2021 at 08:00, outcome "recovered with sequelae" (an unknown date in Nov2021), described as "Loose stools"; VACCINATION SITE PRURITUS (non-serious) with onset 18Nov2021, outcome "recovered with sequelae" (28Nov2021), described as "Itching at the injection site"; VACCINATION SITE ERYTHEMA (non-serious) with onset 18Nov2021, outcome "recovered with sequelae" (28Nov2021), described as "Redness at the injection site"; OLIGOMENORRHOEA (non-serious) with onset 19Nov2021, outcome "not recovered", described as "Extended menstrual cycle"; NERVOUSNESS (non-serious) with onset 18Nov2021, outcome "not recovered", described as "Very nervous". The events "Nausea", "Dizziness", "Emesis", "Loose stools", "Itching at the injection site", "Redness at the injection site", "Extended menstrual cycle" and "Very nervous" were evaluated at the physician office visit. Therapeutic measures were taken as a result of vaccination site pruritus and vaccination site erythema which included PREDNISONE oral tablet x 5 days with relief noted/BENADRYL over the counter (OTC).  Additional Information: Latency of the events nausea and dizziness was 15 minutes and for the events of emesis and loose stools was 12 hours. The patient felt improvement after day 12. The event of nausea was intermitted for approximately 8 days. The events of itching and redness at the injection site (lasted 10 days) and had a bullseye like appearance. The second dose was due 12/9 hence the patient was very nervous about it. The patient did not receive any other vaccines within four weeks prior to COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19.   The lot number for BNT162b2 was not provided and will be requested during follow up.